Sensing the Bactericidal and Bacteriostatic Antimicrobial Mode of Action Using Raman Deuterium Stable Isotope Probing (DSIP) in Escherichia coli.
The study suggests that deuterium stable isotope probing combined with Raman spectroscopy could help identify the mode of action of antibiotics, but specific results and implications for clinical practice are not detailed.
Where it sits
this study against the rest of the dsip corpusSummary and findings
This study investigates the applicability of deuterium stable isotope probing (DSIP) combined with Raman spectroscopy to differentiate between bacteriostatic and bactericidal actions of antibiotics in Escherichia coli. The research focuses on optimizing deuterium oxide concentration for monitoring metabolic activity without hindering microbial growth. Findings suggest that changes in the C-D band intensity can serve as a quantifiable marker for antibiotic mode of action.
Abstract
The mode of action of antibiotics can be broadly classified as bacteriostatic and bactericidal. The bacteriostatic mode leads to the arrested growth of the cells, while the bacteriocidal mode causes cell death. In this work, we report the applicability of deuterium stable isotope probing (DSIP) in combination with Raman spectroscopy (Raman DSIP) for discriminating the mode of action of antibiotics at the community level. <i>Escherichia coli,</i> a well-known model microbe, was used as an organism for the study. We optimized the concentration of deuterium oxide required for metabolic activity monitoring without compromising the microbial growth. Our findings suggest that changes in the intensity of the C-D band in the high-wavenumber region could serve as a quantifiable marker for determining the antibiotic mode of action. This can be used for early identification of the antibiotic's mode of action. Our results explore the new perspective that supports the utility of deuterium-based vibrational tags in the field of clinical spectroscopy. Understanding the antibiotic's mode of action on bacterial cells in a short and objective manner can significantly enhance the clinical management abilities of infectious diseases and may also help in personalized antimicrobial therapy.
Background
The paper addresses the antimicrobial mechanisms of action of DSIP against Escherichia coli, a common pathogenic bacterium. Previous research has established various antimicrobial agents but has not thoroughly explored the specific actions of DSIP. Understanding these mechanisms is crucial for developing effective antimicrobial strategies.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.